Renal Cancer - Results from #6000

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma September 23, 2015

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer September 23, 2015

[Novel biomarkers in renal cell carcinoma : Identification and functional characterization] September 23, 2015

The Prognostic Impact of a Positive Vascular Margin in pT3 Clear Cell Renal Cell Carcinomas September 23, 2015

Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs September 23, 2015

Unusual Malignant Solid Neoplasms of the Kidney: Cross-Sectional Imaging Findings September 23, 2015

The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma. September 23, 2015

Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy September 22, 2015

Trends in Metastatic Kidney Cancer Survival From the Cytokine to the Targeted Therapy Era September 22, 2015

Overview and management of toxicities associated with systemic therapies for advanced renal cell carcinoma September 21, 2015

Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan September 21, 2015

National Trends of Local Ablative Therapy among Young Patients with Small Renal Masses in the United States September 21, 2015

FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma September 21, 2015

Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association September 21, 2015

Renal cell carcinoma in patients with a personal or family history of hematologic malignancies September 17, 2015

Non-clear cell renal cell carcinoma, part 2: therapy September 17, 2015

Non-clear cell renal cell carcinoma, part 1: histology September 17, 2015

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma September 17, 2015

RandomizEd phase 2 trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial September 17, 2015

Activity of aminoferrocene-based prodrugs against prostate cancer September 8, 2015

Page 301 of 456